Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 18, 2000

View Archived Issues

Crucell Plans Dual IPO Following Merger Of IntroGene, U-BiSys

Crystal Structure Of DNA Repair Protein May Hold Cancer Clues

UK First Country To Allow Use Of Genetic Testing By Insurers

Genetix Aims To Raise #27M To Boost Sales Force, R&D

Diatos Raises $13M To Fund Cancer, Infection Programs

Bosentan Gains Orphan Status In Pulmonary Hypertension

Cooperative EU-U.S. Biotech Effort Lauded At 10-Year Mark

Transghne, Mirus Collaborate On Gene Transfer Technology

GenOdyssee Attains Genotyping Objective, Plans To Lower Price

Alizyme Sees Positive Results In Phase IIa Study Of Drug For IBS

New Chairman, Secretary General Settle Into EuropaBio Positions

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.